Teva Pharmaceutical’s Stock Surges Post $23 Billion Global Opioid Settlement

Teva’s stock surged Monday after proclaiming their $23 billion global settlement meant to resolve all allegations against the company for its role in fueling the opioid epidemic. 

The stock rose more than 8%.

Per the settlement deal, Teva would donate the $23 billion in opioid addiction treatment drugs and pay $250 million over 10 years. 

This agreement in principle is with a group of attorneys general from multiple states as well as other defendants.

Read More from Source


    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button